TRT Kingdom names sixteen peptides on its homepage, prices one of them with the plan term attached, and routes its own peptide category address to a single product page — so the catalogue it advertises is not browsable at the address it advertises.
What TRT Kingdom charges
Sermorelin: $233 — TERM-GATED: printed as "$233/mo — 3-month plan" on the product page, immediately after a sentence about whether the compound "may be appropriate as part of a personalized treatment plan". The page publishes no month-to-month alternative, so the figure is only available on a three-month commitment
TRT Kingdom is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A category URL that lands on one product
The path a reader would use to browse this seller's peptides redirects to a product page for a single growth-hormone SKU. The page served is real and useful; it is not a category.
Two things follow. A reader clicking through from the navigation sees one item where they expected a list, and a search engine following the same link indexes one product as the whole category.
This session printed the effective URL beside the requested one on every fetch, which is the only reason the redirect is visible at all. A review citing the requested path would be citing an address the seller does not serve.
The roster cites the effective URL on the price row.
Sixteen named, one priced
The homepage names a wide list of compounds — growth-hormone secretagogues, tissue-repair peptides, a copper peptide, a melanocortin agonist, a coenzyme, an antioxidant, a mitochondrial peptide, a named blend and more.
One of them carries a published figure on the pages read. The rest are named and not priced.
Naming a compound is not the same as offering it at a knowable price, and a comparison that counted catalogue breadth from a homepage word list would rank this seller far above sellers publishing three figures.
This roster records the one compound with a figure, and this review records the gap, because the gap is the fact a reader shopping on breadth most needs.
The term is attached to the number
The product page prints the figure with a month attached and, immediately beside it, the words three-month plan. There is no month-to-month alternative published.
Stating the term in the same breath as the figure is better practice than an asterisk resolving in a footer, and considerably better than the sellers in this batch that state no term at all.
It still means the figure is term-gated. A reader unwilling to commit to three months has no published price here, and this site records the figure as one that is not a monthly rate for that reason.
The sentence preceding the figure frames the compound as something a clinician may or may not find appropriate, rather than as a purchase, which is a small but real difference in how a product page reads.
Both entities named, and no certificate
The privacy policy names the operating company, in two punctuations across two legal documents, and the about page names the clinical practice separately.
Disclosing both the brand operator and the practice is the correct split and it is not universal on this roster — several sellers in this batch publish only a vendor's name or none at all.
Screened by the operating company, by the clinical practice and by the brand against the regulator's warning-letter index, no letter names this seller.
The about page refers to laboratory testing. No certificate, PDF or index is reachable, so it is recorded as a claim rather than as testing. No dispensing pharmacy is named and no state coverage list is published.
Who it's for
Readers who want a plan term printed in the same line as the figure rather than in an asterisk.
Buyers who want both the operating company and the clinical practice named.
Anyone surveying which compounds a clinical seller is willing to name openly.
Shoppers comfortable with a three-month commitment.
Who should look elsewhere
Anyone wanting a month-to-month rate, which is not published.
Readers who want a browsable peptide catalogue, since the category address serves a single product.
Buyers who want figures for more than one of the sixteen compounds named.
Shoppers who want a certificate behind the site's testing language.
Strengths
Prints the plan term in the same breath as the figure rather than in an asterisk
Names both the operating company and the clinical practice, separately, on its own pages
Names a wide peptide list openly on the homepage instead of hiding the catalogue behind an intake
Frames the product as something a clinician may or may not find appropriate rather than as a purchase
Trade-offs
Its peptide category URL resolves to one product, so the catalogue it advertises is not browsable at that address
Only one of the sixteen peptides it names carries a published figure on the pages read
No month-to-month option is published beside the three-month figure
Claims laboratory testing on its about page with no certificate reachable
How we verified this
Loaded the product page and the privacy policy with a full browser user-agent, printing the effective URL beside the requested one on each.
Recorded that the seller's own peptide category path redirects to a single product page, and cited the effective URL on the price row.
Ran a nonsense-path control on the host in the same run, which returned a not-found status.
Joined the page's text nodes before matching any figure, so a price split across elements could not read as an absence.
Recorded the figure as one that is not a monthly rate, because the page attaches a three-month plan to it and publishes no month-to-month alternative.
Counted the compounds named in the homepage text and compared that count against the number carrying a published figure.
Read the privacy policy for the operating company and the about page for the clinical practice.
Screened both entities and the brand against the regulator's warning-letter index, with a nonsense query as a control in the same run.
A provider to compare TRT Kingdom against
Auren Rx
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.